DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AMOXICILLIN; CLAVULANATE POTASSIUM
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMOXICILLIN; CLAVULANATE POTASSIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROMORAMIDE
4
Small molecule
Approved
Unknown
Unknown
Pain
Opioid receptors; mu/kappa/delta agonist
DEXTROMORAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
9S4S6CIY83
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O2
Molecular Weight:
392.54
AlogP:
3.71
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
6.0
Source:
NATRECOR
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
NATRECOR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOCETAMIC ACID
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
IOCETAMIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
FA675Q0E3E
Molecule Type:
Small molecule
Molecular Formula:
C12H13I3N2O3
Molecular Weight:
613.96
AlogP:
3.16
PSA:
83.63
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TYROTHRICIN
4
Protein
Approved
Unknown
Unknown
Eye Infections
Unknown
TYROTHRICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
877376V2XW
Molecule Type:
Protein
Molecular Formula:
C65H85N11O13
Molecular Weight:
1228.46
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PHENOXYPROPAZINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Monoamine oxidase inhibitor
PHENOXYPROPAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8E92V52324
Molecule Type:
Small molecule
Molecular Formula:
C9H14N2O
Molecular Weight:
166.22
AlogP:
0.92
PSA:
47.28
HBD:
2.0
HBA:
#RotB:
4.0
Source:
Botulinum Toxin Type B
4
Unknown
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM
UNKNOWN
Unknown
Unknown
Botulinum Toxin Type B
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; CARISOPRODOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; CARISOPRODOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISATUXIMAB-IRFC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ISATUXIMAB-IRFC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTHIEPIN
4
Small molecule
Approved
Unknown
Unknown
Depressive Disorder
Norepinephrine transporter inhibitor
DOTHIEPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
W13O82Z7HL
Molecule Type:
Small molecule
Molecular Formula:
C19H21NS
Molecular Weight:
295.45
AlogP:
4.68
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SAFFLOWER OIL
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
SAFFLOWER OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
65UEH262IS
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEFPIROME SULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CEFPIROME SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
BA5ALU2ZT9
Molecule Type:
Small molecule
Molecular Formula:
C22H24N6O9S3
Molecular Weight:
612.67
AlogP:
-1.04
PSA:
153.92
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CHLOROBUTANOL
4
Small molecule
Approved
Unknown
Unknown
Nausea
Unknown
CHLOROBUTANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
HM4YQM8WRC
Molecule Type:
Small molecule
Molecular Formula:
C4H7Cl3O
Molecular Weight:
177.46
AlogP:
2.13
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
4
Combination
Approved
OTHER
N/A
Unknown
Unknown
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM LACTATE
4
Small molecule
Approved
Unknown
Unknown
Dental Caries
Unknown
CALCIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
2URQ2N32W3
Molecule Type:
Small molecule
Molecular Formula:
C6H10CaO6
Molecular Weight:
218.22
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TALAMPICILLIN HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TALAMPICILLIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
4C5O3X072I
Molecule Type:
Small molecule
Molecular Formula:
C24H24ClN3O6S
Molecular Weight:
517.99
AlogP:
1.65
PSA:
128.03
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SULFAMETHOXYPYRIDAZINE
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial dihydropteroate synthase inhibitor
SULFAMETHOXYPYRIDAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
T034E4NS2Z
Molecule Type:
Small molecule
Molecular Formula:
C11H12N4O3S
Molecular Weight:
280.31
AlogP:
0.87
PSA:
107.2
HBD:
2.0
HBA:
#RotB:
4.0
Source:
METHAQUALONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
GABA-A receptor; anion channel positive allosteric modulator
METHAQUALONE
×
Maximum Phase:
4
First Approval:
None
UNII:
7ZKH8MQW6T
Molecule Type:
Small molecule
Molecular Formula:
C16H14N2O
Molecular Weight:
250.3
AlogP:
3.0
PSA:
34.89
HBD:
0.0
HBA:
#RotB:
1.0
Source:
DICOBALT EDETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Cyanide sequestering agent
DICOBALT EDETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
UKC6GH80QR
Molecule Type:
Small molecule
Molecular Formula:
C10H12Co2N2O8
Molecular Weight:
406.08
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OMEGA-3ACID ETHYL ESTERS
4
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
OMEGA-3ACID ETHYL ESTERS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
4
Combination
Approved
OTHER
ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOGUANIL PAMOATE
4
Small molecule
Approved
Unknown
Unknown
Malaria
Dihydrofolate reductase inhibitor
CYCLOGUANIL PAMOATE
×
Maximum Phase:
4
First Approval:
None
UNII:
TCO0SY4N3D
Molecule Type:
Small molecule
Molecular Formula:
C45H44Cl2N10O6
Molecular Weight:
891.82
AlogP:
1.53
PSA:
80.0
HBD:
2.0
HBA:
#RotB:
1.0
Source:
incobotulinumtoxinA
4
Unknown
Approved
OTHER
INJECTION
Unknown
Unknown
incobotulinumtoxinA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMOCILLIN
4
Small molecule
Approved
Unknown
Unknown
Bacteremia; Bacterial Infections; Urinary Tract Infections
Bacterial penicillin-binding protein inhibitor
TEMOCILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
03QB156W6I
Molecule Type:
Small molecule
Molecular Formula:
C16H18N2O7S2
Molecular Weight:
414.46
AlogP:
0.52
PSA:
133.24
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TOFOGLIFLOZIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2; Non-alcoholic Fatty Liver Disease
Sodium/glucose cotransporter 2 inhibitor
TOFOGLIFLOZIN
×
Maximum Phase:
4
First Approval:
None
UNII:
P8DD8KX4O4
Molecule Type:
Small molecule
Molecular Formula:
C22H26O6
Molecular Weight:
386.44
AlogP:
1.0
PSA:
99.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
BERGAPTEN
4
Small molecule
Approved
Unknown
Unknown
Dermatitis, Atopic; Psoriasis
Unknown
BERGAPTEN
×
Maximum Phase:
4
First Approval:
None
UNII:
4FVK84C92X
Molecule Type:
Small molecule
Molecular Formula:
C12H8O4
Molecular Weight:
216.19
AlogP:
2.55
PSA:
52.58
HBD:
0.0
HBA:
#RotB:
1.0
Source:
MIDAZOLAM MALEATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MIDAZOLAM MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
77520S18SE
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN3O4
Molecular Weight:
441.85
AlogP:
4.32
PSA:
30.18
HBD:
0.0
HBA:
#RotB:
1.0
Source:
STARCH
4
Oligosaccharide
Approved
Unknown
Unknown
Cerebral Hemorrhage; Fractures, Bone; Infertility; Neoplasms; Psoriasis; Pulmonary Edema; Blood Coagulation Disorders; Hemorrhage; Hypertension; Obesity; Severe Acute Respiratory Syndrome; Subarachnoid Hemorrhage; Temporomandibular Joint Disorders; Diarrhea; Irritable Bowel Syndrome; Malnutrition
Unknown
STARCH
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYCLOTHIAZIDE; PARGYLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
METHYCLOTHIAZIDE; PARGYLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOFLOXACIN; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVOFLOXACIN; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADEFOVIR
4
Small molecule
Approved
Unknown
Unknown
HIV Infections; Hepatitis B, Chronic
DNA polymerase/reverse transcriptase inhibitor
ADEFOVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
6GQP90I798
Molecule Type:
Small molecule
Molecular Formula:
C8H12N5O4P
Molecular Weight:
273.19
AlogP:
-0.44
PSA:
136.38
HBD:
3.0
HBA:
#RotB:
5.0
Source:
1
2
…
300
301
302
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA